Table 2.
Baseline characteristics of participants included in the study
| Study ID | Arms | Age, year | Male, n | Ischemic heart disease | Hypertension | Diabetes | BMI, kg/m2 | QRS width (ms) | EF, % | LVEDV (ml) | LVESV (ml) | NYHA class, n (%) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| II | III | IV | ||||||||||||
| Almusaad et al. [9] | MPP | 61.27 ± 12.93 | 48 | 26 (35.6%) | 47 (64.4%) | 35 (47.9%) | NA | 160.77 ± 16.87 | 26.9 ± 9.45 | 202.33 ± 97.56 | 146.33 ± 77.9 | 11 (15.1%) | 57 (78.1%) | 5 (6.8%) |
| BiV | 59.57 ± 11.29 | 48 | 21 (30.4%) | 34 (49.3%) | 39 (56.5%) | 159.33 ± 15.14 | 26.63 ± 8.18 | 199.6 ± 65.27 | 144.3 ± 67.39 | 16 (23.2%) | 50 (72.5%) | 3 (4.3%) | ||
| Marques et al. [3] | MPP | 64.5 ± 10.2 | 13 | 5 (20.8%) | 20 (83.3%) | 12 (50.0%) | NA | 170 ± 20.49 | 28.7 ± 6.9 | 210.5 ± 81.9 | 153.9 ± 73.2 | 17 (70.8%) | 7 (29.2%) | NA |
| BiV | 66.5 ± 11.6 | 15 | 4 (16%) | 20 (80.0%) | 10 (40.0%) | 162.67 ± 18.87 | 29.6 ± 6.9 | 189.4 ± 53.9 | 134.7 ± 47.1 | 17 (68.0%) | 8 (32.0%) | |||
| Pappone et al. [1] | MPP | 65 ± 9 | 16 | 9 (47%) | NA | NA | NA | 154 ± 17 | 27 ± 7 | 248 ± 62 | 182 ± 56 | NA | 19 (100%) | NA |
| BiV | 67 ± 8 | 15 | 8 (38%) | 152 ± 18 | 30 ± 6 | 237 ± 124 | 169 ± 107 | 21 (100%) | ||||||
| Gu et al. [5] | MPP | 55.8 ± 11.1 | 19 | 4 (15.4%) | 9 (34.6%) | 7 (26.9%) | NA | 161.8 ± 16.3 | 28.2 ± 6.6 | 262.0 ± 81.1 | 173.3 ± 68.8 | 10 (38.5%) | 15 (57.7%) | 1 (3.8%) |
| BiV | 58.7 ± 9.3 | 17 | 4 (16%) | 10 (40%) | 5 (20%) | 159.7 ± 13.0 | 28.7 ± 6.7 | 272.0 ± 82.3 | 185.6 ± 73.1 | 9 (36%) | 16 (64%) | 1 (4%) | ||
| Varma et al. [2] | MPP | LVEDVI > Median: 65 ± 11 years and LVEDVI < Median: 68 ± 10 years | LVEDVI > Median: 17/24(70.8%) and LVEDVI < Median: 11/19(57.9%) | LVEDVI > Median: 62.5 and LVEDVI < Median: 57.9 | NA | NA | NA | LVEDVI > Median: 153 ± 22 and LVEDVI < Median: 158 ± 27 | LVEDVI > Median: 25 ± 6 and LVEDVI < Median: 32 ± 7 | LVEDVI > Median: 241 ± 51 and LVEDVI < Median: 152 ± 33 | LVEDVI > Median: 181 ± 44 and LVEDVI < Median: 106 ± 28 | LVEDVI > Median: 41.7 and LVEDVI < Median: 15.8 | LVEDVI > Median: 37.5 and LVEDVI < Median: 52.6 | LVEDVI > Median: 12.5 and LVEDVI < Median: 5.3 |
| BiV | LVEDVI > Median: 65 ± 11 and LVEDVI < Median: 70 ± 9 | LVEDVI > Median: 78/94(83.0%) and LVEDVI < Median: 56/94(59.6%) | LVEDVI > Median: 51.1 and LVEDVI < Median: 50.0 | LVEDVI > Median: 159 ± 22 and LVEDVI < Median: 150 ± 18 | LVEDVI > Median: 26 ± 7 and LVEDVI < Median: 33 ± 8 | LVEDVI > Median: 252 ± 58 and LVEDVI < Median: 146 ± 27 | LVEDVI > Median: 187 ± 52 and LVEDVI > Median: 99 ± 23 | LVEDVI > Median: 34.0 and LVEDVI < Median: 26.6 | LVEDVI > Median: 53.2 and LVEDVI < Median: 61.7 | LVEDVI > Median: 2.1 and LVEDVI < Median: 2.1 | ||||
| Leclercq et al. [7] | MPP | 68 ± 10 | 438 (81%) | 287 (53%) | NA | NA | NA | 155 ± 26 | 26 ± 8% | NA | 164 ± 68 | 346 (64%) | 104 (19.2%) | NA |
| BiV | 68 ± 11 | 443 (77.7%) | 291 (51.1%) | 153 ± 25 | 26 ± 7% | 163 ± 68 | 353 (61.9) | 105 (18.4%) | ||||||
Include extracted population characteristics, including age, male prevalence, ischemic heart disease, hypertension, diabetes, body mass index (BMI), QRS width, LVEF, left ventricular end diastolic volume (LVEDV), left ventricular end systolic volume (LVESV), and NYHA class